Advertisement

Topics

CardioMEMS Inc Company Profile

18:35 EST 18th November 2017 | BioPortfolio

MEMS (an acronym for MicroElectroMechanical Systems) technology uses semiconductor industry techniques to create micron scale machines incorporating both mechanical and electronic components. The staff of CardioMEMS, Inc. includes pioneers in the development of non-silicon MEMS techniques. Many of the techniques utilized in the design and manufacture of CardioMEMS sensors have been developed only in the past five years. The sensors have been designed for ultra-reliable operation and prolonged stability and durability.
A key circuit element of the sensor is a capacitor composed of two conducting plates separated by an air gap. The plates are electrically interfaced with an inductor/antenna. This circuit has a known resonant frequency. Pressure changes alter the distance between capacitor plates which changes the resonant frequency. An electronic monitoring device detects this change in the sensor's resonant frequency and converts it into a pressure change. The wireless radiofrequency (RF) technology in the monitoring device is proprietary.
This family of implantable wireless pressure sensors represents multiple technology breakthroughs. CardioMEMS, Inc. is the first company to realize the use of this technology to wirelessly gather information from within the human body.

Location

75 Fifth Street, N.W., Suite 440
Atlanta
Georgia
30308
United States of America

Contact

Phone: 404-920-6700
Email: info@cardiomems.com


News Articles [5 Associated News Articles listed on BioPortfolio]

Postmarketing adverse events low for CardioMEMS HF system

(HealthDay)—Postmarketing adverse events related to the CardioMEMS HF System are infrequent, but can be serious, according to a research letter published online Sept. 18 in JAMA Cardiology.

CardioMEMS Trips on PA Injury in Postmarket Surveillance

(MedPage Today) -- Reintervention or device recalibration often needed after PA injury

CardioMEMS PA-Pressure Sensor: Prowess, Cautions in HF Management

The implanted pulmonary-artery-pressure monitor's postmarket registry seem to indicate efficacy at least as good as in the pivotal clinical trial; adverse events reported to MAUDE provide perspective....

Abbott's PA sensor system is clinically proven to work—but how safe is it?

Recent studies have proven Ab

Hope of a New Future for Patients with Heart Failure Using New Implantable Hemodynamic Monitoring Technologies, is Highlighted in New Issue of the Journal of the American College of Cardiology

JACC report features Vectorious Medical Technologies’ digital wireless sensory implant for measuring pressures in the heart. A review appearing in the July 18 issue of the J...

Drugs and Medications [0 Results]

None

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Remote monitoring of pulmonary artery pressures with CardioMEMS in patients with chronic heart failure and NYHA class III: first experiences in the Netherlands.

We report the first patient experiences with the CardioMEMS device in the Erasmus MC Thorax Center in the Netherlands. In line with clinical trial evidence, the device is applicable in patients with c...

Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System.

Heart failure (HF) is a leading cause of cardiovascular mortality in the United States and presents a substantial economic burden. A recently approved implantable wireless pulmonary artery pressure re...

Effects of pressure variation and atrial fibrillation on CardioMEMS(™) HF measured pulmonary artery diastolic pressure: comparison of device-averaged and visually inspected waveforms.

Heart failure (HF) management guided by implantable hemodynamic monitoring reduces hospitalization rates. Hemodynamic data from the CardioMEMS(™) HF system includes device-averaged pulmonary artery ...

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

Registry of Patients With CardioMEMS

CardioMEMS is an implantable wireless hemodynamic monitoring system which can transmit the pulmonary artery pressure. This device is FDA approved to be used as a diagnostic tool to help ma...

CardioMEMS European Monitoring Study for Heart Failure

The purpose of this study is to characterize the use of the CardioMEMS™ HF System when used in a real-world setting.

Bioimpedance Spectroscopy Compared to CardioMEMS™

Comparison of changes in diastolic pulmonary artery pressure as measured by CardioMEMS™ to impedance parameters as measured by ImpediMed's BIS technology.

CardioMEMS HF System OUS Post Approval Study

The purpose of this Post Approval Study (PAS) is to evaluate the use of the CardioMEMS HF System in patients with Class III Heart Failure in a commercial setting.

Correlation of SOZO BIS Measures With CardioMEMS PA Pressure

This study aims to establish the degree to which change in the ratio of ECF to TBW measured using the SOZO BIS device correlates with change in end-expiratory end-diastolic PAP measured us...

Companies [1 Associated Companies listed on BioPortfolio]

CardioMEMS Inc

MEMS (an acronym for MicroElectroMechanical Systems) technology uses semiconductor industry techniques to create micron scale machines incorporating both mechanical and electronic components. The staf...

More Information about "CardioMEMS Inc" on BioPortfolio

We have published hundreds of CardioMEMS Inc news stories on BioPortfolio along with dozens of CardioMEMS Inc Clinical Trials and PubMed Articles about CardioMEMS Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CardioMEMS Inc Companies in our database. You can also find out about relevant CardioMEMS Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record